Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb

International Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 6, 1998, Pages 345-349

  Madej, A ^a   Okopien, B ^a   Kowalski, J ^a   Zielinski, M ^a   Wysocki, J ^a   Szygula, B ^a   Kalina, Z ^a   Herman, Z S ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Fibrates; Hyperlipoproteinemia IIb; Interferon ; Interleukin 1; Tumor necrosis factor

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN B; CYTOKINE; FENOFIBRATE; GAMMA INTERFERON; INTERLEUKIN 1; LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; IMMUNOPATHOLOGY; INFLAMMATORY CELL; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MALE; T LYMPHOCYTE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTILIPEMIC AGENTS; ARTERIOSCLEROSIS; CYTOKINES; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INTERFERON TYPE II; INTERLEUKIN-1; LIPIDS; MALE; MIDDLE AGED; PROCETOFEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031813989     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Al-Janadi M, Al-Balla S, Al-Dalaan A et al 1993 Cytokine profile in systemic lupus erythematosus, rheumathoid arthritis, and other rheumatic diseases. J Clin Immunol 13: 58-63
2. Anderson KM, Castelli WP, Levy D 1987 Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA 257: 2176-2188
3. Dalekos GN, Elisaf M, Bairaktari E et al 1997 Increased plasma levels of Interleukin-1 beta in the systemic circulation of patients with essenial hypertension: additional risk factor for atherogenesis in hypertensive patients? J Lab Clin Med 129: 300-308
4. Davies MJ, Woolf N 1993 Atherosclerosis: What is it and why does it occur? Br Heart J 69: S3
5. Feingold KR, Funk JL, Moser AH et al 1995 Role for circulating lipoproteins in protection from endotoxin toxicity. Infect Immun 63: 2041-2046
6. Feigold KR, Spady DK, Pollock AS et al 1996 Endotoxin, TNF, and Il-1 decrease cholesterol 7 alpha-hydroxylase mRNA levels and activity. J Lipid Res 37: 223-228
7. Geng YJ, Holm J, Nygren S et al 1995 Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T cell cytokine interferon-gamma. Arterioscler Thromb Vasc Biol 15: 1995-2002
8. Hajjar KA, Hajjar DP, Silverslein RL, Nachman RL 1987 Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med 166: 235-245
9. Huang YH, Ronnelid J, Frostegard J 1995 Oxidized LDL induces enhanced antibody formation and MHC class II-dependent IFN-gamma production in lymphocytes from healthy individuals. Arterioscler Thromb Vasc Biol 15: 1577-1583
10. Jovinge S, Ares MP, Kallin B, Nilsson J 1996 Human monocytes/macrophages release TNF-alpha in response to Ox-LDL. Arterioscler Thromb Vasc Biol 16: 1573-1579
11. Kishikawa H, Shimokama T, Watanabe T 1993 Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6, and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis. Virchows Arch A Pathol Anat Histopathol 423: 433-442
12. Knopp KH, Brown WV, Dujovne CA et al 1987 Effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemia. Am J Med 83: 50-59
13. Kosaka C, Masuda J, Shimokado K et al 1992 Interferon-gamma suppresses PDGF production from THP-1 cells and blood monocyte-derived macrophages. Atherosclerosis 97: 68-74
14. Libby P, Sukhova G, Lee RT et al 1995 Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 25: S9-S12
15. O'Brien KD, Chair A 1994 The biology of the artery wall in atherogenesis. Lipid Disorders 78: 41-67
16. Otto C, Ritter MM, Soennichsen AC et al 1996 Effects of n-3 fatty acids and fenofibrate on lipid and hemorrheological parameters in familial dysbetalipoproteinemia and familial hypertriglyceridemia. Metabolism 45: 1305-1311
17. Ross R 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809
18. Ross R 1991 Polypeptide growth factors and atherosclerosis. Trends Cardiovasc Med 1: 277-282
19. Shepherd J 1994 The fibrates in clinical practice: focus on micronised fenofibrate. Atherosclerosis 110: 55-63
20. Steinmetz A, Schwartz T, Hehnke U, Kaffarnik H 1996 Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia. J Cardiovasc Pharmacol 27: 563-570
21. Stemme S, Faber B, Holm J et al 1995 T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 92: 3893-3897
22. Taniguchi N, Itoh K, Honda M et al 1997 Comparative ultrasonographic and angiographic study of carotid arterial lesions in Takayashu's arteritis. Angiology 48: 9-20
23. Thorne SA, Abbot SE, Stevens CE et al 1996 Modified low density lipoprotein and cytokines mediate monocyte adhesion to smooth muscle cells. Atherosclerosis 127: 167-176
24. Tipping PG, Hancock WW 1993 Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol 142: 1721-1728
25. Uno H, Ueki Y, Murashima J et al 1995 Removal of LDL from plasma by adsorption reduces adhesion molecules on mononuclear cells in patients with arteriosclerosis obliterans. Atherosclerosis 116: 93-102
26. Vaddi K, Nicolini FA, Mehta P, Mehta JL 1994 Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischaemic heart diseases. Circulation 90: 694-699
27. Van der Wall AC, Das PK, Tigges AJ et al 1992 Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol 141: 1427-1433
28. Witztum JL, Steinberg D 1992 Role of oxidized LDL in atherogenesis. Br Heart J 69: 512-521